'Game changer' Pfizer pill is easier to find as omicron fade

As the omicron wave peaked in the U.S. last month, the first-line treatment for high-risk patients with early COVID-19 dangled out of reach for most. Only a trickle of the new Paxlovid pill from Pfizer Inc. was reaching hospitals and pharmacies.

Related Keywords

New York , United States , Idaho , Massachusetts , Boston , China , Colorado , Nassau , New Providence , Bahamas , The , Americans , America , Aaron Glatt , Scott Dryden Peterson , Vir Biotechnology Inc , Glaxosmithkline Plc , Eli Lilly Co , Pfizer , Pfizer Inc , Infectious Diseases Society Of America , Massachusetts Medical Society , Department Of Medicine , Asif Merchant , Mount Sinai South Nassau , While Paxlovid , Mass General Brigham , Eli Lilly , Mount Sinai , Infectious Diseases Society , Mass General , New York City ,